Discovery, design and synthesis of Y-shaped peroxisome proliferator- activated receptor δ agonists as potent anti-obesity agents in vivo

  • Jungyeob Ham
  • , Hoosang Hwang
  • , Euno Kim
  • , Jeong Ah Kim
  • , Sung Jin Cho
  • , Jaeyoung Ko
  • , Woojin Lee
  • , Jaehwan Lee
  • , Harish Holla
  • , Joydeep Banerjee
  • , Seokho Kim
  • , Inho Yang
  • , Hyun Joo Lee
  • , Kyoungjin Shin
  • , Hyukjae Choi
  • , Sang Jip Nam
  • , Jungae Tak
  • , Dongyup Hahn
  • , Taekyung Oh
  • , Dong Hwan Won
  • Tae Gu Lee, Jihye Choi, Mi Sun Park, Chaok Seok, Jungwook Chin, Heonjoong Kang

Research output: Contribution to journalArticlepeer-review

Abstract

We have discovered and demonstrated the in vitro and in vivo PPARδ-selective activity of novel Y-shaped agonists. These compounds activated hPPARδ with EC50 values between 1 and 523 nM. Surprisingly, compounds 10a, 11d, 11e and 11f were the most potent and most selective hPPARδ agonists with 104-fold selectivity over the other two subtypes, namely, hPPARα and hPPARγ. The PPARδ ligands 10a, 11e and 11f showed good bioavailability and in vivo efficacy.

Original languageEnglish
Pages (from-to)190-202
Number of pages13
JournalEuropean Journal of Medicinal Chemistry
Volume53
DOIs
StatePublished - Jul 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-obesity
  • GW501516
  • Marine natural products
  • Nuclear receptors
  • PPARδ

Fingerprint

Dive into the research topics of 'Discovery, design and synthesis of Y-shaped peroxisome proliferator- activated receptor δ agonists as potent anti-obesity agents in vivo'. Together they form a unique fingerprint.

Cite this